[1]
|
Chih, H.J., Lee, A.H., Colville, L., et al. (2013) A Review of Dietary Prevention of Human Papillomavirus-Related in-fection of the Cervix and Cervical Intraepithelial Neoplasia. Nutrition and Cancer, 65, 317-328.
https://doi.org/10.1080/01635581.2013.757630
|
[2]
|
Rouzier, R. (2008) Management of CIN1. Journal de Gyné-cologie Obstétrique et Biologie de la Reproduction, 37, S114-S120. https://doi.org/10.1016/j.jgyn.2007.11.017
|
[3]
|
Martin, C.M. and O’Leary, J.J. (2011) Histology of Cervical In-traepithelial Neoplasia and the Role of Biomarkers. Best Practice & Research Clinical Obstetrics & Gynaecology, 25, 605-615. https://doi.org/10.1016/j.bpobgyn.2011.04.005
|
[4]
|
Munro, A., Leung, Y., Spilsbury, K., et al. (2015) Comparison of Cold Knife Cone Biopsy and Loop Electrosurgical Excision Procedure in the Management of Cervical Adenocarcinoma in Situ: What Is the Gold Standard? Gynecologic Oncology, 137, 258-263. https://doi.org/10.1016/j.ygyno.2015.02.024
|
[5]
|
Chen, E.Y., Tran, A., Raho, C.J., et al. (2010) Histological ‘Progression’ from Low (LSIL) to High (HSIL) Squamous Intraepithelial Lesion Is an Uncommon Event and an Indi-cation for Quality Assurance Review. Modern Pathology, 23, 1045-1051. https://doi.org/10.1038/modpathol.2010.85
|
[6]
|
Creagh, T., Bridger, J.E., Kupek, E., et al. (1995) Pathologist Variation in Reporting Cervical Borderline Epithelial Abnormalities and Cervical Intraepithelial Neoplasia. Journal of Clinical Pathology, 48, 59-60.
https://doi.org/10.1136/jcp.48.1.59
|
[7]
|
Cheol Park, G., Roh, J.L., Cho, K.J., et al. (2017) 18F-FDG PET/CT vs. Human Papillomavirus, p16 and Epstein-Barr Virus Detection in Cervical Metastatic Lymph Nodes for Identifying Primary Tumors. International Journal of Cancer, 140, 1405-1412. https://doi.org/10.1002/ijc.30550
|
[8]
|
Woodman, C.B., Collins, S.I. and Young, L.S. (2007) The Natural History of Cervical HPV Infection: Unresolved Issues. Nature Reviews Cancer, 7, 11-22. https://doi.org/10.1038/nrc2050
|
[9]
|
Kim, Y.H., Chang, B., Choi, J.H., et al. (2016) Biochemical Fingerprints of Human Papillomavirus Infection and Cervical Dysplasia Using Cervical Fluids: Spectral Pattern Investigation. Mi-croscopy Research and Technique, 79, 966-972. https://doi.org/10.1002/jemt.22728
|
[10]
|
Wang, L., Wang, P., Ren, Y., et al. (2016) Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China. PLoS One, 11, e0160698.
https://doi.org/10.1371/journal.pone.0160698
|
[11]
|
Syrjanen, K. (2011) Persistent High-Risk Human Papilloma-virus (HPV) Infections as Surrogate Endpoints of Progressive Cervical Disease. Potential New Endpoint for Efficacy Studies with New-Generation (Non-HPV 16/18) Prophylactic HPV Vaccines. European Journal of Gynaecological Oncology, 32, 17-33.
|
[12]
|
Kim, T.E., Kim, H.W. and Lee, K.E. (2014) Distribution of Human Papillomavirus 52 and 58 Genotypes, and Their Expression of p16 and p53 in Cervical Neoplasia. Korean Journal of Pathology, 48, 24-29.
https://doi.org/10.4132/KoreanJPathol.2014.48.1.24
|
[13]
|
Wei, Q., Fu, B., Liu, J., et al. (2013) Combined Detection of p16 (INK4a) and IMP3 Increase the Concordance Rate between Cervical Cytologic and Histologic Diagnosis. International Journal of Clinical and Experimental Pathology, 6, 1549-1557.
|
[14]
|
Xing, Y., Wang, C. and Wu, J. (2017) Expression of Geminin, p16, and Ki67 in Cervical Intraepithelial Neoplasm and Normal Tissues. Medicine (Baltimore), 96, e7302. https://doi.org/10.1097/MD.0000000000007302
|
[15]
|
Serour, Y., Bendahmane, M., Abbou Baker, F., et al. (2017) HPV Test by Hybrid Capture II for the Diagnosis of HR-HPV Persistent Infection. Médecine et Maladies Infectieuses, 47, 484-489.
https://doi.org/10.1016/j.medmal.2017.05.013
|
[16]
|
Seraceni, S., De Seta, F., Colli, C., et al. (2014) High Preva-lence of HPV Multiple Genotypes in Women with Persistent Chlamydia Trachomatis Infection. Infect Agent Cancer, 9, 30. https://doi.org/10.1186/1750-9378-9-30
|
[17]
|
Halec, G., Alemany, L., Lloveras, B., et al. (2014) Pathogenic Role of the Eight Probably/Possibly Carcinogenic HPV Types 26, 53, 66, 67, 68, 70, 73 and 82 in Cervical Cancer. The Journal of Pathology, 234, 441-451.
https://doi.org/10.1002/path.4405
|
[18]
|
Das, C.R., Tiwari, D., Dongre, A., et al. (2018) Deregulated TNF-Alpha Levels along with HPV Genotype 16 Infection Are Associated with Pathogenesis of Cervical Neoplasia in Northeast Indian Patients. Viral Immunology, 31, 282-291.
https://doi.org/10.1089/vim.2017.0151
|
[19]
|
Sari Aslani, F., Safaei, A., Pourjabali, M., et al. (2013) Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions. Iranian Journal of Medical Sciences, 38, 15-21.
|
[20]
|
You, K., Guo, Y.L., Geng, L., et al. (2013) Correlation of Cervical Intraepithelial Neoplasia with Expressions of p16 and Ki67 in Exfoliated Cervical Cells in Fluid-Based Thin-Layer Samples. European Journal of Gynaecological Oncology, 34, 535-539.
|
[21]
|
Volpi, C.C., Ciniselli, C.M., Gualeni, A.V., et al. (2018) In Situ Hybridization Detection Methods for HPV16 E6/E7 mRNA in Identifying Transcriptionally Active HPV Infection of Oropharyngeal Carcinoma: An Updating. Human Pathology, 74, 32-42. https://doi.org/10.1016/j.humpath.2017.09.011
|
[22]
|
Rabachini, T., Boccardo, E., Andrade, R., et al. (2018) HPV-16 E7 Expression Up-Regulates Phospholipase D Activity and Promotes Rapamycin Resistance in a pRB-Dependent Manner. BMC Cancer, 18, 485.
https://doi.org/10.1186/s12885-018-4392-8
|
[23]
|
Guo, C.P., Liu, K.W., Luo, H.B., et al. (2011) Potent Anti-Tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway. PLoS ONE, 6, e17734.
https://doi.org/10.1371/journal.pone.0017734
|
[24]
|
Dreyer, J.H., Hauck, F., Barros, M.H.M., et al. (2017) pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer. Applied Immunohistochemistry & Molecular Morphology, 25, 366-373. https://doi.org/10.1097/PAI.0000000000000309
|
[25]
|
Liu, Y., Alqatari, M., Sultan, K., et al. (2017) Using p16 Immunohistochemistry to Classify Morphologic Cervical Intraepithelial Neoplasia 2: Correlation of Ambiguous Staining Patterns with HPV Subtypes and Clinical Outcome. Human Pathology, 66, 144-151. https://doi.org/10.1016/j.humpath.2017.06.014
|
[26]
|
Golusinski, P., Pazdrowski, J., Szewczyk, M., et al. (2017) Is Immunohistochemical Evaluation of p16 in Oropharyngeal Cancer Enough to Predict the HPV Positivity? Reports of Practical Oncology and Radiotherapy, 22, 237-242.
https://doi.org/10.1016/j.rpor.2017.01.003
|